FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308376695> ?p ?o ?g. }

• W4308376695 abstract "<h3>Background</h3> Checkpoint proteins regulate the immune system. Breast cancer (BC) cells exploit the up-regulation or down-regulation of these proteins to evade anti-tumor immune responses. Soluble forms of immune checkpoint molecules (ICM) can be measured in human plasma; however, their biological and clinical significance remain essentially unknown. The present analysis aimed to measure plasma ICMs in metastatic BC patients (pts) and compare them to healthy controls. <h3>Methods</h3> Soluble forms of ICM and RANTES, arginase and TGF-b1 were measured using Multiplex® bead array and ELISA technologies, respectively. Plasma samples from 20 metastatic breast cancer (MBC) pts and 45 healthy controls were analyzed for each protein. Data was prospectively obtained. Measured levels were compared between MBC pts and healthy controls using a non-parametric test (Mann-Whitney), p-values below 0.05 were considered statistically significant. <h3>Results</h3> The median age of the cohort was 53 years (range 34–79 years). The main metastatic sites included liver (10 pts), bone (8 pts), and lung (6pts), with brain-, nodal-, rectum- and skin metastasis presenting in one patient each. The performance status was as follows; PS=0 (11 patients), PS=1 (7 patients,) and PS=2 (2 patients). The median neutrophil-lymphocyte ratio (NLR) was 3.18 (range 0.35 – 10.97). The soluble co-stimulatory molecules, GITR (p<0.0011), GITRL (p< 0.0000), CD27 (p< 0.0039), CD28 (p<0.0069), CD40 (p< 0.0022), CD86 (p< 0.0000) and ICOS (p< 0.0157), as well as the co-inhibitory molecules, PD-L1 (p< 0.0002), CTLA-4 (p< 0.0002) and BTLA (p<0.0145) levels were significantly lower in MBC pts compared to healthy controls. Inhibitory molecules TIM-3 (p< 0.0001) and LAG-3 (p<0.0000 were significantly higher than those of healthy controls. Other biomarkers with raised serum concentrations included TLR (p<0.0039). Serum CD80 (p<0.0992), PD-1 (p<0.2325), HVEM (p<0.062,6) and RANTES (p<0.4861) levels were not significantly different between the MBC pts and the healthy controls (table 1). <h3>Conclusions</h3> We identified lower levels of CD27, CD28, CD40, ICOS, GITR, GITRL, CD86, PD-L1, CTLA-4, BTLA, arginase, and TGF-β1, and higher levels of TIM-3 and LAG-3 immune checkpoint molecules in MBC pts compared to healthy controls. These results indicate that a down-regulation of soluble ICM pathways and an up-regulation of some inhibitory ICM pathways are associated with MBC patients. To our knowledge, this is the first study to describe soluble immune checkpoint molecules in MBC pts. <h3>Ethics Approval</h3> Ethics approval was granted by The Research Ethics Committee, Faculty of Health Sciences, University of Pretoria (Ethics Committee Approval Numbers 517/2017." @default.
• W4308376695 created "2022-11-11" @default.
• W4308376695 creator A5000185857 @default.
• W4308376695 creator A5001298706 @default.
• W4308376695 creator A5021461215 @default.
• W4308376695 creator A5022681160 @default.
• W4308376695 creator A5023582751 @default.
• W4308376695 creator A5043177871 @default.
• W4308376695 date "2022-11-01" @default.
• W4308376695 modified "2023-09-25" @default.
• W4308376695 title "96 Metastatic breast cancer is associated with increased levels of soluble inhibitory immune checkpoint proteins and decreased levels of soluble stimulatory immune checkpoint proteins" @default.
• W4308376695 doi "https://doi.org/10.1136/jitc-2022-sitc2022.0096" @default.
• W4308376695 hasPublicationYear "2022" @default.
• W4308376695 type Work @default.
• W4308376695 citedByCount "0" @default.
• W4308376695 crossrefType "proceedings-article" @default.
• W4308376695 hasAuthorship W4308376695A5000185857 @default.
• W4308376695 hasAuthorship W4308376695A5001298706 @default.
• W4308376695 hasAuthorship W4308376695A5021461215 @default.
• W4308376695 hasAuthorship W4308376695A5022681160 @default.
• W4308376695 hasAuthorship W4308376695A5023582751 @default.
• W4308376695 hasAuthorship W4308376695A5043177871 @default.
• W4308376695 hasBestOaLocation W43083766951 @default.
• W4308376695 hasConcept C121608353 @default.
• W4308376695 hasConcept C126322002 @default.
• W4308376695 hasConcept C143998085 @default.
• W4308376695 hasConcept C203014093 @default.
• W4308376695 hasConcept C2775930923 @default.
• W4308376695 hasConcept C2776090121 @default.
• W4308376695 hasConcept C2777701055 @default.
• W4308376695 hasConcept C2779013556 @default.
• W4308376695 hasConcept C2780237676 @default.
• W4308376695 hasConcept C2780851360 @default.
• W4308376695 hasConcept C2781101188 @default.
• W4308376695 hasConcept C502942594 @default.
• W4308376695 hasConcept C530470458 @default.
• W4308376695 hasConcept C71924100 @default.
• W4308376695 hasConcept C8891405 @default.
• W4308376695 hasConcept C90924648 @default.
• W4308376695 hasConceptScore W4308376695C121608353 @default.
• W4308376695 hasConceptScore W4308376695C126322002 @default.
• W4308376695 hasConceptScore W4308376695C143998085 @default.
• W4308376695 hasConceptScore W4308376695C203014093 @default.
• W4308376695 hasConceptScore W4308376695C2775930923 @default.
• W4308376695 hasConceptScore W4308376695C2776090121 @default.
• W4308376695 hasConceptScore W4308376695C2777701055 @default.
• W4308376695 hasConceptScore W4308376695C2779013556 @default.
• W4308376695 hasConceptScore W4308376695C2780237676 @default.
• W4308376695 hasConceptScore W4308376695C2780851360 @default.
• W4308376695 hasConceptScore W4308376695C2781101188 @default.
• W4308376695 hasConceptScore W4308376695C502942594 @default.
• W4308376695 hasConceptScore W4308376695C530470458 @default.
• W4308376695 hasConceptScore W4308376695C71924100 @default.
• W4308376695 hasConceptScore W4308376695C8891405 @default.
• W4308376695 hasConceptScore W4308376695C90924648 @default.
• W4308376695 hasLocation W43083766951 @default.
• W4308376695 hasOpenAccess W4308376695 @default.
• W4308376695 hasPrimaryLocation W43083766951 @default.
• W4308376695 hasRelatedWork W144521535 @default.
• W4308376695 hasRelatedWork W2224319365 @default.
• W4308376695 hasRelatedWork W2411890706 @default.
• W4308376695 hasRelatedWork W2904294837 @default.
• W4308376695 hasRelatedWork W3033874287 @default.
• W4308376695 hasRelatedWork W3115896813 @default.
• W4308376695 hasRelatedWork W3181412252 @default.
• W4308376695 hasRelatedWork W3183783449 @default.
• W4308376695 hasRelatedWork W4285025443 @default.
• W4308376695 hasRelatedWork W1606523365 @default.
• W4308376695 isParatext "false" @default.
• W4308376695 isRetracted "false" @default.
• W4308376695 workType "article" @default.